Index
-
Market Cap
13.99B
Enterprise Value
16.69B
Income
448.66M
Sales
8.23B
Book/sh
121.83
Cash/sh
10.80
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
40100
IPO
May 15, 1998
P/E
32.18
Forward P/E
16.07
PEG
9.46
P/S
1.70
P/B
1.53
P/C
17.29
P/FCF
16.86
EV/EBITDA
13.91
EV/Sales
2.03
Quick Ratio
1.32
Current Ratio
1.32
Debt/Eq
0.38
LT Debt/Eq
0.38
Option/Short
Yes / Yes
EPS (ttm)
5.80
EPS next Y
11.62
EPS next Q
2.83
EPS this Y
-15.55%
EPS next Y
9.77%
EPS next 5Y
1.70%
EPS past 3/5Y
-22.33% -14.31%
Sales past 3/5Y
2.15% 24.15%
EPS Y/Y TTM
43.70%
Sales Y/Y TTM
0.67%
EPS Q/Q
142.96%
Sales Q/Q
-2.86%
Insider Own
1.05%
Insider Trans
-5.34%
Inst Own
104.17%
Inst Trans
-3.88%
ROA
2.77%
ROE
4.95%
ROIC
3.56%
Gross Margin
18.99%
Oper. Margin
9.62%
Profit Margin
5.45%
SMA20
-6.46%
SMA50
2.68%
SMA200
26.75%
Trades
Shs Outstand
74.92M
Shs Float
74.13M
52W High
219.04 -14.76%
52W Low
66.57 180.47%
Volatility
3.81% 4.11%
ATR (14)
8.13
RSI (14)
44.58
Beta
1.19
Rel Volume
0.75
Avg Volume
977.00K
Volume
735,236
Perf Week
-4.08%
Perf Month
0.69%
Perf Quarter
7.63%
Perf Half Y
59.88%
Perf YTD
2.46%
Perf Year
18.08%
Perf 3Y
-30.85%
Perf 5Y
-34.76%
Perf 10Y
144.99%
Prev Close
190.36
Price
186.71
Change %
-1.92%
Analysts 12 incl. previous ratings
Rating Distribution 6 Buy · 6 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 09, 2026 Upgrade B BofA Securities
Underperform → Neutral $185 -0.9% Sep 30, 2026 Resumed U UBS
Neutral $195 +4.4% Jun 30, 2026 Upgrade T Truist
Hold → Buy $207 +10.9% Jun 25, 2026 Upgrade R RBC Capital Mkts
Sector Perform → Outperform $185 -0.9% May 18, 2026 Resumed R RBC Capital Mkts
Sector Perform $123 -34.1% Mar 26, 2026 Upgrade B BMO Capital Markets
Market Perform → Outperform $130 -30.4% Feb 23, 2026 Upgrade J Jefferies
Hold → Buy $135 -27.7% Feb 18, 2026 Upgrade T TD Cowen
Hold → Buy $120 -35.7% Feb 17, 2026 Downgrade R Rothschild & Co Redburn
Buy → Neutral $100 -46.4% Feb 12, 2026 Downgrade L Leerink Partners
Outperform → Market Perform $105 -43.8% Feb 12, 2026 Downgrade B BofA Securities
Neutral → Underperform $75 -59.8% Jan 08, 2026 Downgrade T Truist
Buy → Hold $222 +18.9% Dec 15, 2025 Downgrade B BofA Securities
Buy → Neutral $195 +4.4% Nov 13, 2025 Initiated B BMO Capital Markets
Market Perform $175 -6.3% Sep 09, 2025 Downgrade J Jefferies
Buy → Hold $175 -6.3% Sep 03, 2025 Upgrade R Rothschild & Co Redburn
Neutral → Buy $236 +26.4% Aug 21, 2025 Downgrade C Citigroup
Buy → Neutral $200 +7.1% Jul 24, 2025 Upgrade R Robert W. Baird
Neutral → Outperform $224 +20.0% Apr 29, 2025 Downgrade J JP Morgan
Overweight → Neutral $150 -19.7% Apr 14, 2025 Downgrade T TD Cowen
Buy → Hold $157 -15.9%
Show Previous Ratings
Nov-10-26 08:00AM
Nov-05-26 07:00AM
Oct-28-26 10:56AM
(Earnings Whispers)
+17.04%
Oct-27-26 04:43PM
Oct-08-26 08:00AM
08:30AM
Loading…
Aug-20-26 08:30AM
Aug-14-26 06:01PM
Aug-06-26 06:30AM
Aug-04-26 08:39AM
Jul-31-26 04:15PM
Jul-30-26 03:03PM
Jul-29-26 04:15PM
Jul-28-26 10:04AM
07:00AM
Jul-22-26 06:00AM
03:00PM
Loading…
Jun-24-26 03:00PM
Jun-23-26 04:15PM
Jun-22-26 07:00AM
Jun-17-26 04:15PM
May-28-26 07:02PM
May-18-26 09:55AM
May-13-26 08:00AM
Mar-26-26 09:45AM
Mar-24-26 08:00AM
Mar-11-26 06:00AM
Mar-10-26 09:11AM
Mar-09-26 12:17AM
Mar-05-26 09:56AM
Mar-02-26 12:55AM
Mar-01-26 04:23AM
06:45PM
Loading…
Feb-26-26 06:45PM
Feb-24-26 02:46PM
Feb-23-26 09:08PM
(Morningstar Research)
+4.97%
Feb-18-26 10:10AM
Feb-17-26 09:43AM
Feb-15-26 08:32AM
Feb-14-26 08:17AM
Feb-13-26 11:25PM
(Insider Monkey)
+16.13%
-4.71%
Feb-12-26 04:16PM
(Investor's Business Daily)
-39.85%
02:19PM
11:10AM
10:07AM
09:44AM
07:38AM
Feb-11-26 10:00AM
Feb-05-26 07:23PM
(Morningstar Research)
-10.86%
+3.58%
Jan-27-26 07:15AM
Jan-22-26 12:06AM
Jan-05-26 07:27AM
Dec-17-25 08:53AM
Dec-10-25 10:31AM
Dec-09-25 07:46AM
07:15AM
Dec-02-25 07:15AM
Nov-27-25 11:30AM
Nov-26-25 06:27PM
(Morningstar Research)
+5.23%
Nov-25-25 07:46AM
Nov-21-25 11:30AM
Nov-13-25 09:11AM
Nov-12-25 06:45AM
Nov-06-25 07:28PM
Oct-24-25 06:41PM
Oct-23-25 11:15AM
Oct-22-25 05:45PM
04:25PM
Oct-20-25 10:00AM
Oct-15-25 10:00AM
Oct-01-25 06:48PM
(Morningstar Research)
+9.89%
Sep-26-25 08:52AM
Sep-14-25 01:17AM
Sep-09-25 12:11PM
Sep-04-25 08:00AM
Sep-02-25 06:00AM
Sep-01-25 12:20PM
Aug-18-25 06:45PM
Aug-12-25 11:41PM
(Insider Monkey)
+5.87%
+4.26%
08:54AM
Aug-11-25 07:50AM
Aug-06-25 06:42PM
(Morningstar Research)
-6.36%
Jul-25-25 09:45PM
(Morningstar Research)
-4.10%
Jul-24-25 06:37PM
(Morningstar Research)
+16.15%
Jul-23-25 05:50PM
04:20PM
04:15PM
Jul-17-25 10:00AM
Jul-16-25 10:00AM
07:15AM
Jul-15-25 09:32AM
Jul-07-25 07:15AM
07:06AM
Jul-03-25 10:13AM
Jun-27-25 09:15AM
Jun-23-25 06:30AM
Jun-02-25 10:23AM
04:12AM
May-30-25 11:31AM
May-27-25 08:30AM
May-19-25 04:15PM
May-14-25 07:52AM
May-09-25 03:13AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Murray Ciaran Director Nov 12 '26 Sale 200.18 10,000 2,001,765 7,000 Nov 16 04:15 PM CIARAN MURRAY Director Nov 12 '26 Proposed Sale 200.18 10,000 2,001,765 Nov 12 04:07 PM Murray Ciaran Director Nov 02 '26 Sale 205.66 3,452 709,956 17,000 Nov 04 06:30 AM Balfe Barry Edward Chief Executive Officer Nov 02 '26 Sale 206.66 5,175 1,069,441 9,291 Nov 03 04:23 PM Lyons Emer Chief Accounting Officer Nov 02 '26 Sale 206.66 264 54,558 1,217 Nov 03 04:16 PM Clerkin Nigel Bernard John Chief Financial Officer Nov 02 '26 Sale 206.66 1,488 307,503 7,171 Nov 03 04:11 PM NIGEL CLERKIN Officer Nov 02 '26 Proposed Sale 206.65 1,488 307,501 Nov 02 04:11 PM CIARAN MURRAY Director Nov 02 '26 Proposed Sale 205.66 3,452 709,956 Nov 02 04:10 PM BARRY EDWARD BALFE Officer Nov 02 '26 Proposed Sale 206.65 5,175 1,069,434 Nov 02 04:06 PM Lyons Emer Chief Accounting Officer Oct 23 '26 Sale 182.37 272 49,604 990 Oct 26 06:57 AM CLIMAX JOHN DR Director Sep 16 '26 Option Exercise 125.74 5,005 629,329 7,092 Sep 18 06:08 AM CLIMAX JOHN DR Director Sep 16 '26 Sale 175.00 5,005 875,875 2,087 Sep 18 06:08 AM McCague Eugene Pacelli Director Sep 17 '26 Option Exercise 125.74 3,255 409,284 7,066 Sep 18 06:08 AM McCague Eugene Pacelli Director Sep 17 '26 Sale 175.00 3,255 569,625 3,811 Sep 18 06:08 AM Murphy Ronan Martin Director Sep 17 '26 Option Exercise 125.74 5,005 629,329 8,852 Sep 18 06:07 AM Murphy Ronan Martin Director Sep 17 '26 Sale 175.00 5,005 875,875 3,847 Sep 18 06:07 AM EUGENE PACELLI MCCAGUE Director Sep 17 '26 Proposed Sale 175.00 3,255 569,625 Sep 17 04:08 PM RONAN MARTIN MURPHY Director Sep 17 '26 Proposed Sale 175.00 5,005 875,875 Sep 17 04:06 PM JOHN CLIMAX Director Sep 16 '26 Proposed Sale 175.00 5,005 875,875 Sep 16 04:10 PM Whitaker Anne Clem Director Aug 11 '26 Sale 164.29 841 138,168 891 Aug 12 05:02 PM O'Neill Julie Director Aug 11 '26 Sale 164.29 915 150,326 3,515 Aug 12 05:01 PM Murray Ciaran Director Aug 11 '26 Sale 164.29 2,677 439,803 20,452 Aug 12 05:00 PM Murphy Ronan Martin Director Aug 11 '26 Sale 164.29 841 138,168 3,847 Aug 12 05:00 PM McCague Eugene Pacelli Director Aug 11 '26 Sale 164.29 841 138,168 3,811 Aug 12 04:59 PM Grais Linda Director Aug 11 '26 Sale 164.29 841 138,169 6,162 Aug 12 04:47 PM CLIMAX JOHN DR Director Aug 11 '26 Sale 164.29 841 138,168 2,087 Aug 12 04:47 PM Clerkin Nigel Bernard John Chief Financial Officer Aug 11 '26 Sale 164.29 2,267 372,445 5,881 Aug 12 04:46 PM ANNE WHITAKER Director Aug 11 '26 Proposed Sale 164.29 841 138,170 Aug 11 05:12 PM LINDA SUE GRAIS Director Aug 11 '26 Proposed Sale 164.29 841 138,170 Aug 11 05:10 PM EUGENE PACELLI MCCAGUE Director Aug 11 '26 Proposed Sale 164.29 841 138,170 Aug 11 05:09 PM JOHN CLIMAX Director Aug 11 '26 Proposed Sale 164.29 841 138,170 Aug 11 05:06 PM RONAN MARTIN MURPHY Director Aug 11 '26 Proposed Sale 164.29 841 138,170 Aug 11 05:04 PM JULIE ANN O'NEILL Director Aug 11 '26 Proposed Sale 164.29 915 150,327 Aug 11 05:02 PM NIGEL CLERKIN Officer Aug 11 '26 Proposed Sale 164.29 2,267 372,451 Aug 11 05:00 PM CIARAN MURRAY Director Aug 11 '26 Proposed Sale 164.29 2,677 439,810 Aug 11 04:58 PM Balfe Barry Edward Chief Executive Officer Aug 10 '26 Sale 164.07 382 62,676 4,804 Aug 11 04:22 PM BARRY EDWARD BALFE Officer Aug 10 '26 Proposed Sale 164.07 382 62,676 Aug 10 04:02 PM BARRY EDWARD BALFE Officer Mar 09 '26 Proposed Sale 105.13 2,862 300,875 Mar 09 05:14 PM BARRY EDWARD BALFE Officer Mar 04 '26 Proposed Sale 109.25 566 61,837 Mar 04 04:07 PM
ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
CEO & Director Mr. Barry Balfe
Founder & Independent Non-Executive Director Dr. John Climax Ph.D.
Chief Financial Officer Mr. Nigel Clerkin A.C.A.
Chief Commercial Officer Mr. Steve Empoliti
Chief Accounting Officer Lyons Emer